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Roles of the HIF-1 Hypoxia-inducible Factor during Hypoxia Response in
Caenorhabditis elegans
Abstract
The human hypoxia-inducible transcription factor HIF-1 is a critical regulator of cellular and systemic
responses to low oxygen levels. When oxygen levels are high, the HIF-1α subunit is hydroxylated and is
targeted for degradation by the von Hippel-Lindau tumor suppressor protein (VHL). This regulatory pathway
is evolutionarily conserved, and the Caenorhabditis elegans hif-1 and vhl-1 genes encode homologs of the
HIF-1α subunit and VHL. To understand and describe more fully the molecular basis for hypoxia response in
this important genetic model system, we compared hypoxia-induced changes in mRNA expression in wild-
type, hif-1-deficient, and vhl-1-deficient C. elegans using whole genome microarrays. These studies identified
110 hypoxia-regulated gene expression changes, 63 of which require hif-1 function. Mutation of vhl-1
abrogates most hif-1-dependent changes in mRNA expression. Genes regulated by C. elegans hif-1 have
predicted functions in signal transduction, metabolism, transport, and extracellular matrix remodeling. We
examined the in vivo requirement for 16 HIF-1 target genes and discovered that the phy-2 prolyl 4-hydroxylase
α subunit is critical for survival in hypoxic conditions. Some HIF-1 target genes negatively regulate formation
of stress-resistant dauer larvae. The microarray data presented herein also provide clear evidence for an
HIF-1-independent pathway for hypoxia response, and this pathway regulates the expression of multiple heat
shock proteins and several transcription factors.
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The human hypoxia-inducible transcription factor
HIF-1 is a critical regulator of cellular and systemic
responses to low oxygen levels. When oxygen levels are
high, the HIF-1 subunit is hydroxylated and is targeted
for degradation by the von Hippel-Lindau tumor sup-
pressor protein (VHL). This regulatory pathway is evo-
lutionarily conserved, and the Caenorhabditis elegans
hif-1 and vhl-1 genes encode homologs of the HIF-1
subunit and VHL. To understand and describe more
fully the molecular basis for hypoxia response in this
important genetic model system, we compared hypoxia-
induced changes in mRNA expression in wild-type, hif-
1-deficient, and vhl-1-deficient C. elegans using whole
genome microarrays. These studies identified 110 hy-
poxia-regulated gene expression changes, 63 of which
require hif-1 function. Mutation of vhl-1 abrogates most
hif-1-dependent changes in mRNA expression. Genes
regulated by C. elegans hif-1 have predicted functions in
signal transduction, metabolism, transport, and extra-
cellular matrix remodeling. We examined the in vivo
requirement for 16 HIF-1 target genes and discovered
that the phy-2 prolyl 4-hydroxylase  subunit is critical
for survival in hypoxic conditions. Some HIF-1 target
genes negatively regulate formation of stress-resistant
dauer larvae. The microarray data presented herein
also provide clear evidence for an HIF-1-independent
pathway for hypoxia response, and this pathway regu-
lates the expression of multiple heat shock proteins and
several transcription factors.
During development, homeostasis, or disease states, cellular
oxygen levels are often insufficient to meet physiological de-
mands, and this condition is termed hypoxia. Mammalian cells
respond to hypoxia by implementing changes in gene expression
to increase anaerobic energy production, protect cells from stress,
regulate cell survival, and increase local angiogenesis. The req-
uisite changes in gene expression are largely controlled by the
hypoxia-inducible factor 1 (HIF-1)1 transcription factor (1, 2).
HIF-1 is a heterodimeric DNA-binding complex, and both
subunits are members of the family of transcription factors
containing basic-helix-loop-helix and Per-ARNT-Sim domains.
The HIF-1 subunit is also termed ARNT (aryl hydrocarbon
receptor nuclear translocator). Although ARNT can dimerize
with other transcription factors, HIF-1 is apparently dedi-
cated to a hypoxia response (3–5). When oxygen levels are high,
specific proline residues of HIF-1 are hydroxylated by oxygen-
dependent enzymes belonging to the EGL-9/PH superfamily of
2-oxoglutarate-dependent dioxygenases (6, 7). Proline hydroxy-
lation in the conserved LXXLAP motif in HIF-1 increases its
affinity for the von Hippel-Lindau tumor suppressor protein
(VHL), which is part of an E3 ubiquitin-ligase complex that
targets proteins for proteasomal degradation. Thus, when VHL
is disabled by mutation, HIF-1 is expressed at constitutively
high levels (8).
Cells utilize multiple strategies to regulate HIF-1 activity.
HIF-1 is modified post-translationally by hydroxylation, phos-
phorylation, and acetylation (7, 9, 10). Oxygen-dependent hy-
droxylation of the HIF-1 C terminus inhibits binding to the
coactivator CBP/p300 (11, 12). Growth factor stimulation may
modulate HIF-1 transcriptional activity via small GTPases and
mitogen-activated protein kinase cascades (13, 14). The availabil-
ity of interacting proteins, such as transcriptional coactivators,
also influences HIF-1 function. Important questions remain.
What other oxygen-sensing molecules control cellular hypoxia
response? What are the most important VHL-independent mech-
anisms for regulating HIF-1 activity? What fraction of the tran-
scriptional response to hypoxia is controlled by HIF-1?
Caenorhabditis elegans has recently proven to be an impor-
tant model system for studying hypoxia response. The C. el-
egans homolog of the HIF-1 subunit is hif-1, and the HIF-1/
EGL-9/VHL pathway is evolutionarily conserved (6, 15).
C. elegans carrying deletions in the hif-1 gene are apparently
healthy in standard culture conditions, but they exhibit high
levels of lethality in 0.5 or 1% oxygen (15, 16). To identify genes
regulated by HIF-1 during response to hypoxia and to deter-
mine what fraction of hypoxia-induced gene expression
changes is dependent upon hif-1, we conducted genomewide
studies of hypoxia-induced changes in mRNA expression in
wild-type, hif-1-deficient, and vhl-1-deficient C. elegans. These
studies demonstrate that C. elegans hif-1 regulates the major-
ity of early transcriptional responses to hypoxia and provide
clear evidence for HIF-1-independent pathways for adaptation
to oxygen deprivation.
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C. elegans Culture, Microarray Experiments, and Data Analysis—
C. elegans were cultured using standard procedures on NGM plates
with an Escherichia coli food source (17). For hypoxia treatments,
plates containing synchronized third stage larvae were placed either in
room air (normoxia control) or a sealed plexiglass chamber with con-
stant gas flow. Compressed air and pure nitrogen were mixed to achieve
the appropriate oxygen concentration, as assayed by an oxygen sensor
(15). We were most interested in the earliest hif-1-dependent and
hif-1-independent responses to hypoxia. Therefore, we assayed mRNA
expression at the earliest time point at which the F22B5.4 transcript
was consistently induced (4 h at 21 °C in 0.1% oxygen). At the time that
this study was conducted, F22B5.4 was the only C. elegans transcript
shown to be induced by hypoxia. The F22B5.4 putative 5-regulatory
sequences contain multiple elements similar to the mammalian hypoxia
response element (HRE), the DNA binding site for the HIF-1 transcrip-
tional complex, and F22B5.4 is expressed at high levels in egl-9mutants
(6). These data suggested that F22B5.4 might be a direct target for
C. elegans HIF-1. For the microarray experiments, three strains were
assayed: wild-type N2, hif-1 (ia04), and vhl-1 (ok161). Worms were
incubated for 4 h in 21% oxygen or 0.1% oxygen at 21 °C. Animals were
quickly harvested in ice-cold M9 buffer, and poly(A) RNA was isolated
using established procedures. No more than 3 min elapsed between the
removal of plates from the hypoxic chamber and the addition of TRIzol.
The microarray hybridizations were performed by Min Jiang in the
laboratory of Stuart K. Kim at Stanford University (18). cDNA from
animals incubated in 21% O2 (normoxia) was labeled with Cy5, and
cDNA from hypoxia-treated worms was labeled with Cy3. There were
18 mRNA samples: (two oxygen concentrations  three genotypes 
three independent experiments). Each hybridization compared expres-
sion in normoxia versus hypoxia for one genotype, and nine experiments
were performed. The raw data and the normalized data are available at
the Stanford Microarray Data base. The following criteria were used to
filter the data: FLAG  0; failed  0; red and green fluorescence
intensity at least 2-fold above background. We averaged the log2 values
(hypoxia net intensity/normalized normoxia net intensity) from each
experiment. Student’s t test p values were determined with the aver-
ages for each strain.
To identify putative regulatory elements in hif-1-dependent genes, we
used the motif-finding program at bioprospector.stanford.edu (BioPros-
pector). We searched for DNA sequences that were overrepresented in the
18 genes most strongly induced by hypoxia in Table I relative to the 47
hif-1-independent genes. Sequences 200–2,000 bp upstream from each
putative translational start were used for this analysis. Gene cluster
analyses were performed using tools available at PlantGDB (19).
Viability Assays—To create DNA constructs for bacteria-mediated
RNAi, cDNAs provided by Yuji Kohara were subcloned into the L4440
double-T7 vector (20). When cDNAs were not available, coding se-
quences were PCR amplified using primers designed by Valerie Reinke
(21). The resulting constructs were transformed into E. coli strain
HT115 (DE3) (20). RNAi analyses were performed as described previ-
ously (22). Additionally, embryonic and larval viability was assayed in
the following mutant strains: hif-1 (ia04), cam-1 (gm122), egl-9 (sa307),
fmo-12 (ok299), fmo-14 (ok294), inx-2 (ok376), phy-2 (ok177), and vab-1
(e2). Assays for viability at 21 or 0.5% O2 at 21 °C were performed as
described previously (16). Three independent experiments were con-
ducted for each condition, and Student’s t test was used to judge
whether averaged values differed significantly.
RNA Blots—Total RNAs were isolated from synchronized L3 stage
wild-type (Bristol strain N2) worms, hif-1 (ia04) mutants, vhl-1 (ok161)
mutants, and hif-1 (ia04) vhl-1 (ok161) double mutants that had been
incubated for 4 h in normoxia or hypoxia (0.5% O2). The RNA samples
were fractionated via agarose-formaldehyde gel electrophoresis and
transferred to nylon membranes. DNA probes for RNA blot analyses
were amplified using published primers (21). Hybridizations were per-
formed using [-32P]dCTP-labeled probes, and signals were detected
and quantified using a phosphorimager.
GFP Reporter Analysis—To generate the phy-2:GFP construct
pSH01, DNA was PCR amplified using the primers Phy2PF2 (PstI)
5-ggcgctgcagAGACTATAGTCTATAGCTGAAAACG and Phy2PR2
(BamHI) 5-gcgggatccACTGCTCTCATTCTGAAAGACAAATC. The
PCR product includes the phy-2 sequence from 1715 bp to 11 bp
relative to the translational start site (23). These regulatory sequences
were cloned into GFP vector pPD95.75 (provided by A. Fire, Carnegie
Institution of Washington). To create transgenic animals, the DNA was
coinjected with the pRF-4 rol-6 marker (24). Five independent trans-
genic lines were examined.
RESULTS
The primary goals of these studies were to identify hypoxia-
induced gene expression changes in C. elegans and to deter-
mine which of these responses to hypoxia were regulated by
hif-1. Toward these aims, we analyzed mRNA expression pat-
terns in synchronized populations of wild-type worms that
were cultured in standard laboratory conditions (normoxia) or
in hypoxia. We also assayed mRNA from two mutant strains:
(a) animals carrying the strong loss-of-function mutation in
hif-1 and (b) C. elegans that carry a deletion in vhl-1 and
express the HIF-1 protein at constitutively high levels. RNA
was isolated from three independent experiments for each ex-
perimental condition (three genotypes; normoxia versus hy-
poxia). mRNAs were hybridized to whole genome microarrays
that contained probes for 17,817 predicted genes (94% of the
genome). To identify hypoxia-induced gene expression changes
in wild-type worms, we used two criteria. First, we identified
genes that exhibited a significant difference in mRNA levels in
hypoxia versus normoxia as judged by Student’s t test, p value
0.05. Second, we focused on genes that showed an average
hypoxia-induced difference in mRNA expression greater than
or equal to 2-fold. 110 genes met both of these criteria. To deter-
mine which of these gene expression changes were dependent
upon hif-1 function, we examined the data from hif-1 (ia04)
mutants. 63 of the 110 hypoxia-responsive genes were not signif-
icantly regulated by hypoxia in hif-1 (ia04) mutants (p value 
0.05), and they are listed in Table I. In this article, we will refer
to this class of genes as “hif-1-dependent. ” The 47 genes listed in
Table II were expressed at significantly higher or lower levels in
hypoxia in hif-1-deficient animals (p value  0.05; Table II), and
we will refer to them as “hif-1-independent” genes. In most cases,
hypoxia caused increased gene expression, but 6 of the hif-1-
dependent genes and 3 of the hif-1-independent genes were
down-regulated by hypoxia. A total of 654 genes met less strin-
gent criteria for hypoxia-responsive genes (1.5-fold average
difference between hypoxia and normoxia treatments; p 
0.05), and they are listed in the supplemental data.
To validate further the microarray data and to compare
directly the expression of certain genes in the presence or
absence of hif-1 and vhl-1 function, we analyzed the expres-
sion of a subset of the hypoxia-induced genes on RNA blots.
C. elegans hypoxia has been defined as oxygen concentrations
between 0.1 and 2% (25, 26). To confirm that the gene ex-
pression changes detected by our microarray analyses were
induced by another oxygen concentration in this range, we
repeated the experiments using 0.5% oxygen. We tested eight
of the hif-1-dependent genes. One of these genes, F57B9.1,
was not expressed at levels detectable by RNA blot analysis.
The other seven genes were (a) induced by hypoxia in wild-
type animals; (b) expressed at lower levels in hif-1-defective
mutants; (c) expressed at higher levels in animals lacking
vhl-1 function; and (d) expressed at low levels in double
mutants, consistent with VHL-1 acting as a regulator of
HIF-1 (Fig. 1A). Genes were chosen for RNA blot analysis
based on signal intensity, level of differential expression,
and, in some cases, predicted function. The seven hif-1-de-
pendent genes tested (and their predicted functions) were
fmo-12 (flavin-containing monooxygenase), F22B5.4 (un-
known function), W07A12.7 (acyltransferase), phy-2 (prolyl 4-hy-
droxylase  subunit), nhr-57 (nuclear hormone receptor), egl-9
(2-oxoglutarate-dependent oxygenase), and K10H10.2 (cysteine
synthase). We assayed four of the hif-1-independent genes listed
in Table II by RNA blots. They were F26A3.4 (phosphatase),
C12C8.1 (Hsp70), F44E5.5 (Hsp70), and R166.5 (serine/threo-
nine kinase). All four were induced by hypoxia in wild-type ani-
mals and in mutants lacking hif-1 or vhl-1 function (Fig. 1B).

















Although the hypoxia-responsive genes are located on all six
chromosomes, 40% of the hif-1-dependent genes are on chro-
mosome II, and many of these are found in clusters (Fig. 2).
Three genes (F45D11.1, F45D11.2, and F45D11.16) are within
50 kb of each other at the left arm of II. Multiple small clusters
are located at the center of the chromosome, and a 10-kb
domain on the right arm of II contains two hif-1-dependent
genes (K10H10.2 and K10H10.4). With one exception (two hif-
1-independent genes on chromosome III), hypoxia-responsive
genes on the other four autosomes or on the X are not clustered.
We anticipated that some of the hif-1-dependent genes would
be direct targets of the HIF-1 transcriptional complex. The
mammalian HIF-1 and  subunits form a heterodimer and
bind to specific DNA sequences (HREs) that contain the se-
quence 5-RCGTG (27). A survey of the sequences 200–2,000 bp
5 to the predicted translational start sites shows that the motif
TABLE I
63 genes regulated by hypoxia in a hif-1-dependent manner




ratio (p value) HRE
b
fmo-12 Flavin-containing monooxygenase family member 6.31 (0.035) 0.78 (0.381) 1.50 (0.53)
W07A12.6 Predicted acyltransferase containing T on B-box 6.14 (0.005) 0.80 (0.537) 0.93 (0.74) 2
F22B5.4 Unknown function 6.02 (0.003) 1.21 (0.646) 1.24 (0.58) 4
W07A12.7 Predicted acyltransferase 5.58 (0.005) 0.81 (0.531) 1.21 (0.83) 3
phy-2 Prolyl 4-hydroxylase subunit/collagen synthesis 4.85 (0.005) 1.18 (0.641) 1.42 (0.32) 3
Y44A6C.1 Unknown function 4.59 (0.031) 1.83 (0.300) 1.97 (0.20) 1
efk-1 Homologous to eEF-2 kinase 4.21 (0.004) 1.74 (0.122) 1.98 (0.69) 1
nhr-57 Nuclear hormone receptor family member 4.09 (0.004) 1.80 (0.093) 1.72 (0.10) 4
F59B10.4 Unknown function 3.89 (0.007) 1.81 (0.100) 1.47 (0.24) 1
egl-9 Dioxygenase that negatively regulates hif-1 3.70 (0.003) 1.11 (0.796) 1.74 (0.088) 1
F45D11.16 Unknown function 3.42 (0.030) 0.98 (0.818) 1.62 (0.43)
C24B9.9 Unknown function 3.24 (0.016) 1.24 (0.658) 1.56 (0.27) 1
dpf-6 Dipeptidyl peptidase IV family member 3.18 (0.009) 0.47 (0.029) 0.91 (0.52) 1
W04E12.4 Unknown function 3.17 (0.008) 1.72 (0.114) 2.50 (0.025)
C31G12.2 Contains domain found in C-type lectins 3.16 (0.015) 1.54 (0.228) 2.46 (0.031)
Y38E10A.23 Unknown function 3.12 (0.038) 1.78 (0.159) 2.74 (0.03) 1
R10D12.1 Sodium/phosphate transporter 3.11 (0.038) 1.40 (0.446) 0.79 (0.46)
K10H10.2 Cysteine synthase 3.07 (0.026) 0.92 (0.677) 1.18 (0.61) 3
npp-6 Predicted nuclear pore complex protein 3.05 (0.030) 1.62 (0.238) 1.96 (0.17)
C34D4.14 Predicted ubiquitin-protein ligase 3.04 (0.016) 1.01 (0.969) 1.47 (0.24)
Y15E3A.5 Unknown function 3.00 (0.016) 1.67 (0.181) 2.59 (0.022)
inx-2 Innexin/putative gap junction protein 2.98 (0.019) 0.73 (0.244) 1.10 (0.83)
K04H4.2 Predicted extracellular chitin-binding protein 2.98 (0.018) 0.63 (0.123) 0.58 (0.091)
C04A2.1 Protein containing RabGAP/TBC domain 2.97 (0.006) 1.10 (0.755) 1.06 (0.85) 1
npc-1/ncr-1 Transmembrane protein orthologous to human NPC1 2.96 (0.002) 1.56 (0.084) 1.67 (0.050)
T25E12.4 Serine/threonine protein kinase 2.92 (0.000) 1.23 (0.220) 2.00 (0.004) 1
M01H9.3 Unknown function 2.89 (0.016) 1.53 (0.300) 1.94 (0.095) 2
F45D11.1 Protein containing DUF684 domain 2.87 (0.039) 0.90 (0.750) 2.07 (0.10) 1
CC8.2 Putative phosphatase regulatory subunit 2.85 (0.004) 1.37 (0.206) 1.93 (0.023)
K02E7.6 Protein containing DUF684 domain 2.71 (0.025) 1.02 (0.944) 1.31 (0.48)
fmo-14 Homologous to hepatic flavin-containing monooxygenase 5 2.66 (0.010) 1.18 (0.679) 1.12 (0.69) 1
K08E3.1 Tyrosinase/ predicted oxidoreductase activity 2.64 (0.002) 1.26 (0.326) 1.96 (0.010) 4
F45D11.2 Protein containing DUF684 domain 2.56 (0.023) 0.94 (0.691) 1.73 (0.11)
F16G10.10 Protein containing DUF130 domain 2.46 (0.006) 1.28 (0.332) 2.22 (0.010)
C56E6.2 Ras GTPase superfamily member 2.43 (0.021) 1.49 (0.265) 1.76 (0.11) 1
smg-2 Regulator of nonsense-mediated mRNA decay 2.38 (0.029) 1.11 (0.780) 1.15 (0.77)
cam-1 Receptor tyrosine kinase orthologous to human ROR1, ROR2 2.37 (0.004) 0.82 (0.290) 0.86 (0.32)
F57B9.1 Putative pyridoxamine-phosphate oxidase 2.36 (0.002) 1.10 (0.708) 0.97 (0.70)
F21D12.3 Putative transmembrane amino acid transporter protein 2.35 (0.003) 0.92 (0.474) 1.20 (0.40) 2
T08G3.6 Unknown function 2.34 (0.007) 1.51 (0.134) 1.85 (0.034)
pqn-43 Large protein containing prion-like (Q/N-rich) domains 2.32 (0.044) 1.14 (0.778) 1.50 (0.27) 3
M02F4.1 Unknown function 2.32 (0.019) 0.78 (0.291) 1.29 (0.54) 2
Y46G5A.6 Protein containing F-box and helicase domains 2.28 (0.015) 1.50 (0.125) 1.37 (0.21)
zyg-9 Spindle pole component/regulates microtubule assembly 2.28 (0.016) 1.12 (0.643) 1.61 (0.11) 1
M05D6.5 Protein containing hypoxia-induced protein conserved region 2.28 (0.009) 1.06 (0.897) 1.46 (0.16)
C34B7.3 Cytochrome P450 2.28 (0.001) 0.79 (0.134) 1.09 (0.75) 1
str-257 Member of the seven-transmembrane receptor gene class 2.25 (0.017) 1.31 (0.299) 1.88 (0.043)
T28F3.1 Protein containing copine and C2 domains 2.23 (0.038) 1.57 (0.250) 2.56 (0.053) 1
vab-1 Eph receptor tyrosine protein kinase 2.18 (0.004) 1.50 (0.052) 2.26 (0.003)
Y55F3BR.4 Predicted extracellular ligand-gated ion channel 2.17 (0.016) 1.26 (0.439) 1.39 (0.21) 1
let-75 Pharynx-specific type II myosin heavy chain (MHC D) 2.17 (0.039) 0.65 (0.087) 0.76 (0.32)
C40D2.4 Homeobox-containing protein 2.16 (0.022) 1.08 (0.939) 1.55 (0.14)
C29F9.5 Similarity to p300 transcriptional coactivator 2.15 (0.024) 1.42 (0.227) 2.25 (0.022) 1
C36A4.9 Putative acetyl-coenzyme A synthetase 2.15 (0.021) 0.96 (0.790) 1.87 (0.063)
K10H10.4 Unknown function 2.13 (0.003) 1.25 (0.221) 1.37 (0.14)
C32D5.12 Similarity to sterol dehydrogenases 2.11 (0.017) 1.36 (0.332) 1.04 (0.85)
Y19D10A.5 Transporter belonging to major facilitator superfamily 2.10 (0.004) 0.84 (0.244) 0.91 (0.48)
C01G6.9 Limited homology to human cetriolin 0.36 (0.008) 1.03 (0.748) 1.20 (0.37)
C41C4.1 Protein containing DUF595 domain 0.41 (0.043) 0.68 (0.622) 1.06 (0.80) 1
F35D11.10 Contains domain found in C-type lectins 0.43 (0.016) 0.83 (0.405) 0.93 (0.75)
T07D1.3 Aldehyde dehydrogenase domain 0.47 (0.044) 1.23 (0.374) 2.56 (0.010)
Y9C9A.12 Protein containing F-box domain 0.46 (0.007) 0.78 (0.222) 0.91 (0.92)
F13H8.4 Unknown 0.48 (0.022) 0.71 (0.284) 0.84 (0.60)
a H/N  mRNA expression in a hypoxic condition relative to mRNA levels in a normoxic condition.
b HRE  5-TACGTG, a motif similar to mammalian HRE, in the predicted 5-regulatory region of the gene.

















5-TACGTG is present in 46% of the hif-1-dependent genes
(Table I). In comparison, this putative HRE is present in only
23% of hif-1-independent genes (Table II).
Functions of Hypoxia-responsive Genes—Metabolic enzymes
are prevalent in both Table I and Table II. For example, pyc-1
encodes pyruvate carboxylase, a key enzyme in gluconeogene-
sis, and it was induced by hypoxia in an hif-1-independent
manner (2.2-fold; p value 0.038). Some glycolytic enzymes were
induced at lower levels. F14B4.2 hexokinase, R05F9.6 phos-
phoglucomutase, T21B10.2 enolase, and R11F4.1 glycerol ki-
nase are expressed 1.4–1.9-fold higher levels in hypoxia rela-
tive to normoxia (p 0.05). Two enzymes predicted to facilitate
the conversion of fatty acids to sugars were also induced by
hypoxia. C05E4.9/gei-7 (isocitrate lyase) and F54H12.1/aco-2
(aconitate hydratase) were induced 2.8-fold and 1.8-fold, re-
spectively (Table II and supplemental data).
Predicted signaling molecules are another major functional
class in both Tables I and II. For example, F26A3.4, an hif-1-
independent gene, encodes a protein-tyrosine phosphatase sim-
ilar to the mammalian mitogen-activated protein kinase phos-
phatase 6. Additionally, cam-1, a receptor tyrosine kinase
orthologous to human ROR1 and ROR2, and the dpf-6 dipep-
tidyl peptidase, which is predicted to hydrolyze peptide ligands,
are both hif-1-dependent genes.
Hypoxia appeared to induce changes in extracellular matri-
ces. The phy-2 prolyl 4-hydroxylase  subunit gene and the
bli-3 NADPH oxidase were induced by hypoxia, and both have
central roles in collagen synthesis (28, 29) (Tables I and II,
respectively). Genes encoding three predicted extracellular
molecules with lectin domains (C31G12.2, F35D11.10, and
F47C12.2) and one predicted chitin-binding protein (K04H4.2)
also exhibited hypoxia-responsive mRNA expression (Tables I
and II).
Interestingly, we found that egl-9 mRNA levels were in-
duced by hypoxia in an hif-1-dependent manner (Fig. 1A).
The egl-9 gene encodes a 2-oxoglutarate-dependent oxygen-
ase, and it is thought to be the sole HIF prolyl hydroxylase
(PHD) in C. elegans. Using oxygen as a substrate, EGL-9
TABLE II
47 genes regulated by hypoxia independently of hif-1 function





F26A3.4 Protein containing dual specificity phosphatase domain 10.04 (0.004) 4.71 (0.029) 5.13 (0.015)
F26H11.3 Predicted transcription factor containing a bromodomain 8.76 (0.019) 4.69 (0.048) 6.41 (0.035)
C12C8.1 Member of the Hsp70 family of heat shock proteins 5.60 (0.025) 11.73 (0.009) 11.34 (0.005)
F08H9.4 Member of the Hsp16 family of heat shock proteins 5.28 (0.016) 6.79 (0.004) 2.1 (0.14)
F44E5.5 Member of the Hsp70 family of heat shock proteins 4.87 (0.027) 7.66 (0.012) 17.3 (0.001)
R166.5 Protein containing serine/threonine kinase domain 4.52(0.023) 3.54 (0.042) 3.16 (0.050)
F44E5.4 Member of the Hsp70 family of heat shock proteins 4.49 (0.038) 6.45 (0.021) 15.06 (0.001)
F45D3.4 Unknown function 3.06 (0.040) 4.18 (0.030) 1.73 (0.021)
W02D9.10 Unknown function 3.02 (0.007) 3.80 (0.004) 2.71 (0.014)
C07D10.2 Protein containing BTB/ POZ protein binding domain 2.99 (0.001) 1.74 (0.022) 1.65 (0.036)
bli-3 NADPH oxidase required for dityrosine cross-linking of collagen 2.92 (0.0096) 1.77 (0.048) 1.54 (0.15)
M04G7.3 Unknown function 2.91 (0.008) 1.97 (0.036) 1.89 (0.037)
gei-7 Predicted isocitrate lyase/malate synthase 2.82 (0.015) 2.87 (0.027) 2.54 (0.026)
tbx-33 T-box family transcription factor 2.77 (0.002) 1.94 (0.016) 2.39 (0.007)
Y41D4B.22 Unknown function 2.72 (0.006) 2.06 (0.025) 2.98 (0.005)
Y22D7AR.1 Predicted protein-tyrosine phosphatase 2.60 (0.018) 2.00 (0.042) 3.29 (0.009)
F58D5.8 Unknown function 2.55 (0.004) 2.14 (0.009) 2.40 (0.006)
ZK470.2 Unknown function 2.54 (0.008) 1.93 (0.027) 2.12 (0.019)
ptr-8 Member of the patched related family of transmembrane
glycoproteins
2.51 (0.016) 2.76 (0.012) 1.78 (0.067)
Y39G8B.2 Member of aldo/ketoreductase family 2.49 (0.006) 2.10 (0.013) 2.55 (0.007)
Y75B8A.3 Predicted carboxylesterase 2.47 (0.024) 1.75 (0.013) 3.70 (0.005)
H23N18.3 Similar to UDP glucuronosyltransferases 2.40 (0.024) 2.04 (0.036) 1.48 (0.22)
Y75B8A.6 Predicted DNA-binding protein with two zinc finger domains 2.39 (0.006) 2.24 (0.010) 2.52 (0.007)
sca-1 Sarco/endoplasmic reticulum Ca2 ATPase homolog; ortholog of
human ATP2A1
2.32 (0.031) 2.73 (0.044) 1.60 (0.17)
Y39G10AR.3 Protein containing RCC1 (regulator of chromosome condensation)
domain
2.31 (0.017) 2.23 (0.024) 2.87 (0.007)
lin-42 Homolog of period PAS domain protein 2.29 (0.024) 2.34 (0.033) 2.60 (0.017)
F38B7.2 Unknown function 2.26 (0.021) 2.53 (0.010) 1.51 (0.17)
Y75B8A.19 Unknown function 2.26 (0.023) 2.50 (0.021) 2.24 (0.031)
F47C12.2 Predicted extracellular protein containing lectin and CUB domains 2.25 (0.024) 1.88 (0.045) 2.86 (0.012)
pyc-1 Orthologous to the human gene pyruvate carboxylase 2.24 (0.038) 2.66 (0.018) 2.40 (0.018)
K03B4.4 Unknown function 2.21 (0.011) 1.79 (0.049) 1.86 (0.044)
nhr-88 Member of the nuclear hormone receptor family 2.21 (0.019) 1.96 (0.048) 2.76 (0.008)
unc-14 Protein that binds the UNC-51 protein kinase 2.21 (0.002) 1.78 (0.009) 1.87 (0.006)
F30B5.4 Unknown function 2.20 (0.004) 1.93 (0.11) 2.30 (0.004)
K02F6.7 Unknown function 2.20 (0.012) 1.83 (0.045) 2.90 (0.004)
mxl-3 Basic helix-loop-helix family of DNA-binding proteins; orthologous
to human MAX
2.18 (0.018) 2.39 (0.011) 2.74 (0.009)
E03H4.12 Predicted glucuronyltransferase 2.18 (0.004) 1.94 (0.011) 2.16 (0.005)
tax-6 Ortholog of calcineurin A 2.16 (0.015) 1.92 (0.033) 1.7 (0.047)
T16H12.5 Protein containing MATH and BTB/POZ protein binding domains 2.14 (0.017) 1.86 (0.047) 1.27 (0.37)
ZK849.1 Protein containing PDZ domain 2.12 (0.006) 1.61 (0.036) 1.71 (0.019)
F40E12.2 Large intracellular protein with ankyrin and BRCT domains 2.11 (0.022) 1.76 (0.041) 2.58 (0.009)
F18A12.8 Encodes neprilsin; cleaves small signaling peptides 2.11 (0.000) 2.12 (0.000) 2.40 (0.0002)
tbx-38 T-box family transcription factor 2.07 (0.027) 2.41 (0.018) 2.22 (0.023)
mod-5 Sodium chloride-dependent serotonin transporter 2.05 (0.008) 1.61 (0.043) 2.03 (0.010)
ins-22 Predicted type- insulin-like molecule 0.28 (0.024) 0.42 (0.132) 0.35 (0.045)
T12B5.13 Protein containing FTH protein interaction domains 0.41 (0.023) 0.50 (0.049) 0.63 (0.21)
srv-22 Member of the class V serpentine receptor family 0.42 (0.002) 0.64 (0.030) 0.57 (0.016)
a H/N  mRNA expression in a hypoxic condition relative to mRNA levels in a normoxic condition.

















hydroxylates HIF-1 in the conserved LXXLAP motif. This
modification increases the affinity of HIF-1 for the VHL-1 E3
ligase, which targets HIF-1 for proteosomal degradation. In
egl-9-deficient animals, HIF-1 protein is expressed at consti-
tutively high levels (6).
hif-1 function was required for hypoxia-dependent regula-
tion of smg-2, efk-1, and a predicted ubiquitin ligase
(C34D4.14) (Table I). These gene products are predicted to act
post-transcriptionally to change cellular proteosomes. smg-2 is
required for the degradation of mRNAs containing early non-
sense codons. The gene efk-1 is strongly induced by hypoxia,
and it encodes a calcium/calmodulin-dependent kinase with
homology to human elongation factor-2 kinase (eEF-2 kinase).
eEF-2 kinase decreases protein synthesis by phosphorylating
and inactivating elongation factor 2. Mammals activate eEF-2
kinase activity upon oxygen deprivation (30). Thus, modulation
of protein synthesis via eEF-2 kinase may be an important
aspect of adaptation to changing oxygen levels.
Interestingly, many of the hif-1-independent genes listed in
Table II are transcription factors and heat shock proteins. 17%
(8/47) of hif-1-independent genes are predicted transcriptional
regulators. In comparison, only 5% (3/63) of the hif-1-depend-
ent genes are likely transcription factors, and this is similar to
the prevalence of predicted transcription factors in the com-
plete genome (31). The C. elegans heat shock protein genes
C12C8.1, F08H9.4, F44E5.5, and F44E5.4 were all induced
4.5–5.6-fold by hypoxia, and induction of these heat shock
proteins does not require hif-1 function (Table II).
Many other C. elegans researchers have performed microar-
ray experiments to identify genes that were expressed differ-
entially during specific developmental stages or in response to
diverse environmental stresses. Computational analyses of
these data have resulted in the identification of “mountains” of
coexpressed genes (32). We note that 43% of the hif-1-independ-
ent (20/47) and 13% of the hif-1-dependent genes (8/63) are in
“mountain 1,” an 1,818-gene cluster enriched in genes with
neuronal or muscle function.
Essential Functions for Individual hif-1-dependent Genes—
Mutants lacking hif-1 function exhibit a much higher level of
embryonic and larval lethality in hypoxic conditions compared
with wild-type C. elegans. Thus, we anticipated that certain
individual HIF-1 target genes might also be critical for survival
in hypoxia. To test this hypothesis, we used existing mutant
strains or RNAi to examine the requirement for 16 individual
hif-1-dependent genes in hypoxia. We tested 7 strains carrying
loss-of-function mutations in hif-1-dependent genes, and 5 of
the strains exhibited a statistically significant decrease in em-
bryonic or larval viability in 0.5% oxygen relative to wild-type
animals. As shown in Fig. 3, animals carrying loss-of-function
mutations in fmo-12, fmo-14, vab-1, or inx-2 were slightly more
vulnerable to hypoxic stress than were wild-type worms.
The most dramatic hypoxia-dependent phenotypes were ev-
ident in animals carrying a strong loss-of-function mutation in
the phy-2 prolyl 4-hydroxylase  subunit. Prior studies have
shown that the phy-2 prolyl 4-hydroxylase  subunit has a
central role in collagen synthesis, and genetic analyses have
shown that in normal culture conditions the developmental
functions of phy-2 could also be provided by dpy-18 (23, 33). As
shown in Fig. 3, only 22.3% of phy-2 (ok177) mutant animals
successfully completed embryogenesis in 0.5% oxygen. 97% of
wild-type animals and 58.2% of hif-1 (ia04) embryos hatched in
the same conditions. Animals lacking dpy-18 function were
relatively healthy in hypoxia (94% hatch; n  91). These data
show that dpy-18 cannot completely compensate for loss of
phy-2 function when oxygen is limiting.
When phy-2 (ok177) mutants were allowed to complete em-
bryogenesis in normal culture conditions and then transferred
to a hypoxic chamber (0.5% oxygen) to complete development,
79% were sterile as adults (n  38). This was unexpected
because expression of a phy-2:lacZ transgene has been reported
to be predominantly hypodermal (23). To examine the phy-2
expression pattern in live animals, we constructed a phy-2:GFP
reporter. phy-2:GFP was strongly expressed in the hypodermis,
excretory cell, and spermatheca (Fig. 4). These data are con-
sistent with the hypothesis that collagen synthesis in the sper-
matheca is important to fertility and embryonic viability.
We used RNAi to examine the requirement for an additional
9 hif-1-dependent genes. These assays required culturing the
animals on plates containing isopropyl 1-thio--D-galactopy-
ranoside and tetracycline, and worms grown on control bacteria
in these conditions showed increased sensitivity to hypoxia
(Fig. 5). Worms treated with RNAi for the genes F22B5.4
(unknown function), nhr-57 (nuclear hormone receptor),
K10H10.2 (cysteine synthase), or M05D6.5 (protein containing
a hypoxia-inducible domain) exhibited higher levels of embry-
onic lethality in 0.5% oxygen (Fig. 5).
Molecular Links between Hypoxia Response and Dauer For-
mation—Some of the genes induced by hypoxia also regulate
entry into the dauer phase, an alternative larval stage charac-
terized by low metabolic rate and resistance to environmental
stress. Mutations that favor dauer formation generally also
confer longevity and resistance to certain environmental
stresses. At sufficiently high temperatures, oxygen deprivation
is toxic to wild-type C. elegans, and this experimental regimen
has been termed hypoxic death. Interestingly, specific muta-
tions in the daf-2 insulin-like growth factor receptor gene con-
fer resistance to hypoxic death (34). Loss-of-function mutations
in daf-2 also cause constitutive dauer formation and increased
longevity. These phenotypes are suppressed by mutations that
decrease the function of DAF-16, a forkhead transcription fac-
tor (35, 36). In our microarray experiments, daf-16 mRNA was
induced 1.7–1.9-fold by hypoxia in wild-type, hif-1 (ia04), or
vhl-1 (ok161) worms (p 0.02 to p 0.05) (supplemental data).
We performed RNA blot analyses to validate these findings,
and these experiments showed that expression of daf-16mRNA
FIG. 1. RNA blot analyses of genes regulated by hif-1 or vhl-1.
mRNA was isolated from wild-type (WT), hif-1 (ia04), vhl-1 (ok161), or
double mutant animals after incubation in 21% oxygen (N) or 0.5%
oxygen (H) for 4 h at 21 °C. inf-1 serves as a loading control.

















was 2-fold higher in worms treated with 0.5% oxygen for 4 h
compared with normoxia-treated worms (Fig. 1C). Thus, in-
creased daf-16 expression is a common feature of both hypoxia
response and of perturbations in the DAF-2 signaling pathway
which lead to constitutive dauer formation, increased longev-
ity, and enhanced stress resistance (Fig. 6).
The hif-1-dependent genes in Table I include the npc-1NPC1
homolog and the cam-1 receptor tyrosine kinase. Both of these
genes have been shown to regulate dauer formation negatively.
The human NPC1 gene is structurally related to the patched
family of receptors, and it regulates intracellular cholesterol
transport. Loss of human NPC1 function is associated with
Niemann-Pick type C disease. The C. elegans genome encodes
two NPC1 homologs, and deletion of either gene results in slow
growth and hypersensitivity to cholesterol deprivation. Inacti-
vation of both npc-1 and npc-2 causes a constitutive dauer
phenotype (37, 38). Other studies have shown that mutants
lacking the cam-1 kinase domain form dauers constitutively
when they are cultured at 27 °C, a temperature slightly higher
than the normal physiological range for C. elegans (39). This
temperature-dependent phenotype was especially intriguing
because hif-1 (ia04) mutants are unable to acclimate to high
temperatures (40). Collectively, these data suggested that hif-
1-defective worms might exhibit a dauer constitutive pheno-
type at high temperatures. We tested this hypothesis and de-
termined that hif-1 (ia04) mutants grew slower than wild-type
worms at 27 °C, and 98% of the hif-1 mutants arrested as
partial dauers (n  236). Upon arrest, the hif-1 (ia04) partial
dauers were thin; they pumped their pharynxes slowly and
sporadically; and they had thick cuticles.
VHL-1 Regulates HIF-1 Function and Other Unknown Path-
way(s)—Prior studies had demonstrated that C. elegans lack-
ing vhl-1 function express HIF-1 protein at constitutively high
levels (6). Thus, we predicted that hypoxia-dependent changes
in gene expression induced by HIF-1 would be abrogated in
vhl-1-defective mutants but that inactivation of vhl-1 would
have little effect on hif-1-independent genes. Our data gener-
ally validate these models. For 60 of the 63 hif-1-dependent
genes, regulation by hypoxia was diminished in vhl-1 (ok161)
mutants, and 50 of the genes did not show a significant differ-
ence (p 0.05) between mRNA levels in hypoxia and normoxia.
In contrast, 39 of the 47 genes in Table II exhibited significant
regulation by hypoxia in vhl-1 mutants.
Close examination of the raw data also provided evidence
that VHL has hif-1-independent functions. The gene R03A10.4
(predicted glutamine-phenylpyruvate transaminase) was not
FIG. 2. Genomic distribution of hypoxia-responsive genes. Genes that are induced by hypoxia in wild-type, but not hif-1 (ia04) animals,
are listed in red. Genes induced by hypoxia independently of hif-1 function are listed in blue.

















regulated by hypoxia, and mutation of hif-1 had little effect on
its expression. However, animals lacking vhl-1 function ex-
pressed R03A10.4 at nearly undetectable levels (Fig. 1D).
Thus, VHL-1 appears to act through an HIF-1-independent
mechanism to positively regulate the expression of R03A10.4.
DISCUSSION
Cellular response to changing environmental levels of oxy-
gen is critical for the survival of all metazoans. This study
represents the first genomewide analysis of hypoxia response
in C. elegans and demonstrates that hif-1 function is required
for the majority of mRNA expression changes in C. elegans
hypoxia response. We have also presented compelling evidence
for one or more HIF-1-independent pathways for implementing
transcriptional responses to low oxygen.
In humans response to hypoxia plays a central role in angio-
genesis, tumor development, and cardiovascular disease. The
hypoxia-inducible factor is thought to be the most important
transcriptional regulator of mammalian hypoxic response dur-
ing normal development and disease states (1, 14). Studies
from other research groups have identified many genes regu-
lated by HIF-1. Some of the genes that are transcriptionally
activated by mammalian HIF-1 induce systemic responses to
oxygen deprivation, such as increased red blood cell production
and angiogenesis. Other HIF-1 targets modify the extracellular
matrix, regulate glucose metabolism, or contribute to cellular
survival in stressful conditions (41).
Consistent with studies of mammalian HIF-1 function and
with physiological studies of C. elegans oxygen utilization, we
found that hypoxia induced the expression of many genes that
FIG. 3. Viability assays in normoxia (21% oxygen) and hypoxia
(0.5% oxygen). Animals carrying strong loss-of-function mutations in
downstream targets of HIF-1 were incubated in 0.5% oxygen (hypoxia)
or room air (normoxia) for 24 h and then assayed for successful com-
pletion of embryogenesis (A) and survival to adulthood as described
previously (16) (B). Numerical values are listed in Table S2 (supple-
mental data). Asterisks indicate that the viability of hypoxia-treated
mutants is significantly lower than that of wild-type (WT).
FIG. 4. phy-2:GFP expression in an adult hermaphrodite. The
positions of the vulva and the spermathecas are indicated with a star
and an s, respectively.
FIG. 5. Bacteria-mediated RNAi of nine downstream targets of
HIF-1. The percentage of C. elegans that completed embryogenesis and
hatched is shown. Numerical values are listed in Table S3 (supplemen-
tal data).
FIG. 6. Models for hypoxia signaling and response. A, proteaso-
mal degradation of HIF-1 is mediated by EGL-9 and VHL-1 (6). B,
response to hypoxia is mediated by HIF-1 and by HIF-1-independent
pathway(s). The four largest functional categories of genes induced by
each pathway are shown. HIF-1 positively regulates the expression of
npc-1 and cam-1, which are negative regulators of dauer formation.
This is consistent with constitutive dauer formation of hif-1 (ia04)
mutants at 27 °C. daf-16 mRNA expression is induced by hypoxia
independently of hif-1 function.

















regulate cellular metabolism. Adult C. elegans do not have a
complex circulatory system and are 1 mm in length. Any cell
in the worm is only a few cell widths from the outer cuticle or
the intestinal lumen (42), and oxygen delivery is likely accom-
plished by diffusion. Thus, we anticipated that the transcrip-
tional targets of the C. elegans HIF-1 complex would regulate
cell-autonomous responses to oxygen deprivation. C. elegans
can maintain near normal metabolic rates at environmental
oxygen concentrations as low as 2% (25), and wild-type animals
survive oxygen concentrations as low as 0.1% (26). In hypoxia
(0.1–1% oxygen), C. elegans have been shown to decrease feed-
ing, movement, and oxygen consumption (25).
The Oxygen-requiring PHDs phy-2 and egl-9 are hif-1-de-
pendent Genes—The prolyl 4-hydroxylase enzymes that modify
collagen in the endoplasmic reticulum require oxygen as a
substrate. C. elegans has been shown to encode three prolyl
4-hydroxylase  subunits. The expression pattern of phy-2
overlaps with that of two other  subunits, phy-1 and phy-3, in
the hypodermis and in the spermatheca, respectively. The ma-
jority of the proteins in the worm cuticle are collagens, and
double mutants lacking phy-1 and phy-2 function are inviable
(23, 33, 43). As shown in Fig. 1, C. elegans phy-2 mRNA was
induced by hypoxia in an hif-1-dependent manner. Transcrip-
tional regulation of the prolyl 4-hydroxylase  subunits by HIF
appears to be evolutionarily conserved (44). We have shown
that phy-2-defective animals exhibit lethality and sterility in
hypoxic conditions. These data fit a model in which phy-2
function, and perhaps increased transcription of phy-2, is re-
quired to offset decreased availability of oxygen substrate in
hypoxic conditions.
The EGL-9 PHD modifies HIF-1, thereby increasing its af-
finity for the VHL-1 E3 ligase that targets HIF-1 for proteoso-
mal degradation (6). Data in Table I and Fig. 1 show that egl-9
mRNA levels are regulated by C. elegans hif-1. This is in
agreement with a recently published independent study (42).
Positive regulation of egl-9 transcription by HIF-1 should help
to maintain EGL-9 activity when oxygen substrate is limiting,
and it may create a negative feedback loop to attenuate HIF-1
activation (Fig. 6). In humans, three PHD genes (EGL-9 ho-
mologs) have been identified, and PHD2 and PHD3 are induced
by hypoxia (6, 45, 46). Thus, this regulatory mechanism is
evolutionarily conserved.
In mammals, HIF-1 also induces the expression of CITED2,
which competes with CBP/p300 for binding to HIF-1, thereby
inhibiting transcriptional activation by HIF-1. HIF-1 tran-
scriptional repressors have not yet been identified in C. el-
egans. The C. elegans homologs of HIF-1 and CBP have been
shown to bind each other in yeast two-hybrid assays (47), but it
is not yet known whether interaction of the native proteins is
regulated by environmental oxygen concentrations.
hif-1-independent Pathway(s) for Hypoxia Response—Rela-
tively little is known about the oxygen sensors and regulatory
pathways that mediate transcriptional responses independent
of HIF. The data presented in Table II and Fig. 1B clearly
demonstrate that there are hif-1-independent mechanisms for
hypoxia adaptation in C. elegans. Consistent with these find-
ings, others have shown recently that the transcription of cer-
tain hsp16 small heat shock proteins is induced by hypoxia,
and this induction does not require hif-1 function (48).
For all 47 of the hif-1-independent genes, hypoxia causes
significant differences in expression in the absence of hif-1
function, but in some cases, such as the F26A3.4 phosphatase,
the gene expression change is 2-fold less than that seen in
wild-type animals (Fig. 1B). This supports a model in which
some genes are regulated by hypoxia via both hif-1-dependent
and hif-1-independent pathways.
To compare hypoxia-induced changes in mRNA levels in
different genetic backgrounds, we assayed animals from a de-
fined developmental stage (L3) and at a single early time point.
We expect that assays performed at other oxygen concentra-
tions or other developmental stages will reveal additional hy-
poxia-responsive genes. Early HIF-1 targets likely control later
responses to oxygen deprivation. 67 of the hypoxia-responsive
genes in Tables I and II have known or predicted functions, and
26 of these are expected to mediate transcription or intracellu-
lar protein-protein interactions. For example, F26A3.4 (listed
at the top of Table II) encodes a protein-tyrosine phosphatase
similar to the mammalian mitogen-activated protein kinase
phosphatase 6. Predicted transcription factors induced by hy-
poxia include the nuclear hormone receptors nhr-57 and nhr-88
and the T-box family members tbx-33 and tbx-38.
Oxygen Levels and the Dauer Decision—Dauers are resistant
to several types of stress, including oxygen deprivation (34).
Recent analyses have also shown that the putative HIF-1 bind-
ing site (HRE) is overrepresented in the putative regulatory
sequences of genes up-regulated in dauers (49). This had led to
the hypothesis that HIF-1 may act in concert with DAF-16 (the
forkhead transcription factor that promotes longevity and
dauer formation) to regulate some of the genes that confer
resistance to hypoxic stress (49). As illustrated in Figs. 1 and 6,
hypoxia increases both daf-16 expression and HIF-1 activity.
Interestingly, some of the genes induced by HIF-1 inhibit dauer
formation, and hif-1-defective animals form dauer-like larvae
at high temperatures, even in the presence of abundant food.
Because hif-1 mutants are unable to acclimate to higher tem-
peratures (40), dauer formation may allow survival of stressful
conditions that might otherwise be lethal to animals that are
not expressing HIF-1 target genes at sufficient levels.
Some responses to oxygen stress are post-translational. A
recent study demonstrated that C. elegans will aerotax from
21% oxygen to 7% oxygen, and this response is mediated by
gcy-35, which encodes an oxygen-sensing guanylate cyclase
(50). C. elegans are standardly cultured in the laboratory in
room air (21% oxygen). In the wild, C. elegans inhabits the soil,
and the oxygen levels in soil containing ample supplies of its
bacterial food source could be substantially below 21%. In fu-
ture studies, it will be interesting to investigate whether the
expression of hypoxia-responsive genes varies significantly be-
tween 21% oxygen and the lower oxygen levels preferred by
C. elegans.
The microarray experiments reported here were not de-
signed to compare gene expression patterns in vhl-1 mutant
and wild-type animals directly, but we did find one gene that
was regulated by VHL-1 but not HIF-1. An independent study
has recently been published which identified additional C. el-
egans genes regulated by vhl-1 independently of hif-1 (42). This
is especially interesting because mutations have been identi-
fied in the mammalian VHL tumor suppressor protein which
predispose individuals to carcinomas, but do not impair HIF-1
ubiquitination (51, 52). Further studies of HIF-1 and VHL
homologs in C. elegans may shed light on the shared and
distinct cellular pathways that regulate tumorigenesis.
Acknowledgments—Mutant strains were obtained from the Caenorh-
abditis Genetics Center, which is supported by the National Institutes
of Health National Center for Research Resources. Yuji Kohara and
colleagues provided cDNA constructs. We are grateful to Qunfeng Dong,
who generated the graphic shown in Fig. 2.
REFERENCES
1. Semenza, G. L. (2001) Trends Mol. Med. 7, 345–350
2. Wenger, R. H. (2002) FASEB J. 16, 1151–1162
3. Jiang, B. H., Semenza, G. L., Bauer, C., and Marti, H. H. (1996) Am. J. Physiol.
271, C1172–C1180
4. Ryan, H. E., Lo, J., and Johnson, R. S. (1998) EMBO J. 17, 3005–3015
5. Iyer, N. V., Leung, S. W., and Semenza, G. L. (1998) Genomics 52, 159–165

















6. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O’Rourke, J.,
Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian,
Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J.,
Maxwell, P. H., Pugh, C. W., Schofield, C. J., and Ratcliffe, P. J. (2001) Cell
107, 43–54
7. Bruick, R. K., and McKnight, S. L. (2001) Science 294, 1337–1340
8. Kim, W., and Kaelin, W. G., Jr. (2003) Curr. Opin. Genet. Dev. 13, 55–60
9. Jeong, J. W., Bae, M. K., Ahn, M. Y., Kim, S. H., Sohn, T. K., Bae, M. H., Yoo,
M. A., Song, E. J., Lee, K. J., and Kim, K. W. (2002) Cell 111, 709–720
10. Richard, D. E., Berra, E., Gothie, E., Roux, D., and Pouyssegur, J. (1999)
J. Biol. Chem. 274, 32631–32637
11. Dames, S. A., Martinez-Yamout, M., De Guzman, R. N., Dyson, H. J., and
Wright, P. E. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5271–5276
12. Freedman, S. J., Sun, Z. Y., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G.,
and Eck, M. J. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5367–5372
13. Semenza, G. (2002) Biochem. Pharmacol. 64, 993–998
14. Hopfl, G., Ogunshola, O., and Gassmann, M. (2004) Am. J. Physiol. 286,
R608–R623
15. Jiang, H., Guo, R., and Powell-Coffman, J. A. (2001) Proc. Natl. Acad. Sci.
U. S. A. 98, 7916–7921
16. Padilla, P. A., Nystul, T. G., Zager, R. A., Johnson, A. C., and Roth, M. B. (2002)
Mol. Biol. Cell 13, 1473–1483
17. Brenner, S. (1974) Genetics 77, 71–94
18. Jiang, M., Ryu, J., Kiraly, M., Duke, K., Reinke, V., and Kim, S. K. (2001) Proc.
Natl. Acad. Sci. U. S. A. 98, 218–223
19. Dong, Q., Schlueter, S. D., and Brendel, V. (2004) Nucleic Acids Res. 32,
354–359
20. Timmons, L., and Fire, A. (1998) Nature 395, 854
21. Reinke, V., Smith, H. E., Nance, J., Wang, J., Van Doren, C., Begley, R., Jones,
S. J., Davis, E. B., Scherer, S., Ward, S., and Kim, S. K. (2000) Mol. Cell 6,
605–616
22. Kamath, R. S., Martinez-Campos, M., Zipperlen, P., Fraser, A. G., and
Ahringer, J. (2001) Genome Biology http://genomebiology.com/2001/2/1/
research/0002
23. Winter, A. D., and Page, A. P. (2000) Mol. Cell. Biol. 20, 4084–4093
24. Mello, C. C., Kramer, J. M., Stinchcomb, D., and Ambros, V. (1991) EMBO J.
10, 3959–3970
25. Van Voorhies, W. A., and Ward, S. (2000) J. Exp. Biol. 203, 2467–2478
26. Nystul, T. G., and Roth, M. B. (2004) Proc. Natl. Acad. Sci. U. S. A. 101,
9133–9136
27. Wang, G. L., and Semenza, G. L. (1993) J. Biol. Chem. 268, 21513–21518
28. Edens, W. A., Sharling, L., Cheng, G., Shapira, R., Kinkade, J. M., Lee, T.,
Edens, H. A., Tang, X., Sullards, C., Flaherty, D. B., Benian, G. M., and
Lambeth, J. D. (2001) J. Cell Biol. 154, 879–891
29. Myllyharju, J. (2003) Matrix Biol. 22, 15–24
30. Horman, S., Beauloye, C., Vertommen, D., Vanoverschelde, J. L., Hue, L., and
Rider, M. H. (2003) J. Biol. Chem. 278, 41970–41976
31. C. elegans Sequencing Consortium (1998) Science 282, 2012–2018
32. Kim, S. K., Lund, J., Kiraly, M., Duke, K., Jiang, M., Stuart, J. M., Eizinger,
A., Wylie, B. N., and Davidson, G. S. (2001) Science 293, 2087–2092
33. Friedman, L., Higgin, J. J., Moulder, G., Barstead, R., Raines, R. T., and
Kimble, J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4736–4741
34. Scott, B. A., Avidan, M. S., and Crowder, C. M. (2002) Science 296, 2388–2391
35. Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993) Nature
366, 461–464
36. Larsen, P. L., Albert, P. S., and Riddle, D. L. (1995) Genetics 139, 1567–1583
37. Sym, M., Basson, M., and Johnson, C. (2000) Curr. Biol. 10, 527–530
38. Zhang, M., Li, J., Chakrabarty, P., Bu, B., and Vincent, I. (2004) Am. J. Pathol.
165, 843–853
39. Ailion, M., and Thomas, J. H. (2003) Genetics 165, 127–144
40. Treinin, M., Shliar, J., Jiang, H., Powell-Coffman, J. A., Bromberg, Z., and
Horowitz, M. (2003) Physiol. Genomics 14, 17–24
41. Semenza, G. L. (2003) Nat. Rev. Cancer 3, 721–732
42. Bishop, T., Lau, K. W., Epstein, A. C., Kim, S. K., Jiang, M., O’Rourke, D.,
Pugh, C. W., Gleadle, J. M., Taylor, M. S., Hodgkin, J., and Ratcliffe, P. J.
(2004) PLoS Biol. 2, e289
43. Riihimaa, P., Nissi, R., Page, A. P., Winter, A. D., Keskiaho, K., Kivirikko,
K. I., and Myllyharju, J. (2002) J. Biol. Chem. 277, 18238–18243
44. Takahashi, Y., Takahashi, S., Shiga, Y., Yoshimi, T., and Miura, T. (2000)
J. Biol. Chem. 275, 14139–14146
45. D’Angelo, G., Duplan, E., Boyer, N., Vigne, P., and Frelin, C. (2003) J. Biol.
Chem. 278, 38183–38187
46. Cioffi, C. L., Liu, X. Q., Kosinski, P. A., Garay, M., and Bowen, B. R. (2003)
Biochem. Biophys. Res. Commun. 303, 947–953
47. Nasrin, N., Ogg, S., Cahill, C. M., Biggs, W., Nui, S., Dore, J., Calvo, D., Shi,
Y., Ruvkun, G., and Alexander-Bridges, M. C. (2000) Proc. Natl. Acad. Sci.
U. S. A. 97, 10412–10417
48. Hong, M., Kwon, J. Y., Shim, J., and Lee, J. (2004) J. Mol. Biol. 344, 369–381
49. McElwee, J. J., Schuster, E., Blanc, E., Thomas, J. H., and Gems, D. (2004)
J. Biol. Chem. 279, 44533–44543
50. Gray, J. M., Karow, D. S., Lu, H., Chang, A. J., Chang, J. S., Ellis, R. E.,
Marletta, M. A., and Bargmann, C. I. (2004) Nature 430, 317–322
51. Hoffman, M. A., Ohh, M., Yang, H., Klco, J. M., Ivan, M., and Kaelin, W. G., Jr.
(2001) Hum. Mol. Genet. 10, 1019–1027
52. Clifford, S. C., Cockman, M. E., Smallwood, A. C., Mole, D. R., Woodward,
E. R., Maxwell, P. H., Ratcliffe, P. J., and Maher, E. R. (2001) Hum. Mol.
Genet. 10, 1029–1038

















Chuan Shen, Daniel Nettleton, Min Jiang, Stuart K. Kim and Jo Anne Powell-Coffman
Caenorhabditis elegans
Roles of the HIF-1 Hypoxia-inducible Factor during Hypoxia Response in 
doi: 10.1074/jbc.M501894200 originally published online March 21, 2005
2005, 280:20580-20588.J. Biol. Chem. 
  
 10.1074/jbc.M501894200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  














 on June 20, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
